Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
313.89
+8.18 (2.68%)
May 11, 2026, 9:38 AM EDT - Market open
Krystal Biotech Employees
Krystal Biotech had 295 employees as of December 31, 2025. The number of employees increased by 20 or 7.27% compared to the previous year.
Employees
295
Change (1Y)
20
Growth (1Y)
7.27%
Revenue / Employee
$1,414,590
Profits / Employee
$762,814
Market Cap
9.25B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 295 | 20 | 7.27% | 295 | 0 |
| Dec 31, 2024 | 275 | 46 | 20.09% | 275 | 0 |
| Dec 31, 2023 | 229 | 19 | 9.05% | 229 | 0 |
| Dec 31, 2022 | 210 | 91 | 76.47% | 210 | 0 |
| Dec 31, 2021 | 119 | 44 | 58.67% | 119 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Axsome Therapeutics | 1,220 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
KRYS News
- 4 days ago - Krystal Biotech to Present at BofA Securities 2026 Health Care Conference - GlobeNewsWire
- 6 days ago - Krystal Biotech price target raised to $300 from $295 at Evercore ISI - TheFly
- 6 days ago - Krystal Biotech price target raised to $378 from $371 at Citi - TheFly
- 6 days ago - Krystal Biotech price target lowered to $311 from $338 at Clear Street - TheFly
- 7 days ago - Krystal Biotech Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - Krystal Biotech sees FY26 R&D and SG&A expense $175M-$195M - TheFly
- 7 days ago - Krystal Biotech reports Q1 EPS $1.83, consensus $1.42 - TheFly
- 7 days ago - Krystal Biotech Announces First Quarter 2026 Financial and Operating Results - GlobeNewsWire